
GI GENOA GI Effects®Comprehensive Profile
(Gastrointestinal Test)
-
Chronic constipation, diarrhea, abdominal discomfort and bloating are often placed in the category of "IBS"; or irritable bowel syndrome (Irritable Bowel Syndrome).
-
Sometimes there are underlying causes of Irritable Bowel Syndrome that are not detected by conventional tests.
-
Food allergies, malabsorption, parasites, fungi, bacterial imbalances, and inflammation can all contribute to Irritable Bowel Syndrome.
Investment Q5800
Test + 6 follow-up appointments Q6990


Stool Analysis - (Gastro Intestinal Effects Comprehensive Stool Profile)
- Provides information about inflammation, and how you digest and absorb the food you eat. In addition, the profile offers a detailed description related to the balance of healthy and unhealthy fungi, parasites and bacteria that live in our large intestine.
- This bacterial population is called the microbiome. Many patients do not realize that, in addition to gastrointestinal complaints, systemic diseases can be linked to the gastrointestinal tract.
- By improving the health of your gut, you can improve your overall health.
There is no health without gut health

The Gastrointestinal Effects Profile Stool Test is the most comprehensive test available for immediate insight into gastrointestinal health management.
It uses state-of-the-art technologies and biomarkers to provide valuable information on intestinal function, inflammation and the intestinal microbiome.
The report presents the results in a novel assessment scale that helps with therapeutic recommendations to prioritize treatment according to the test findings.
Biomarkers are grouped and scored in 5 main areas related to gastrointestinal function.

Why is the test important and unique? GI Effects
-
It is a complete test of intestinal health, and determines the reason for the gastrointestinal discomfort.
-
It uses a combination of methods:PCR, culture, and microscopic evaluation to ensure that each and every organism is identified.
-
recover living organisms (yeast and bacteria) for susceptibility testing and improved treatment options.
